dailyhornet.com
Prescription-Strength Zantac Recalled Over Cancer Risk
GlaxoSmithKline (GSK) has issued a global recall for prescription-strength Zantac® heartburn medications due to "unacceptable" levels of a cancer-causing chemical in the pills.